Annual SG&A
$33.76 M
+$1.20 M+3.70%
31 December 2023
Summary:
Repare Therapeutics annual selling, general & administrative expenses is currently $33.76 million, with the most recent change of +$1.20 million (+3.70%) on 31 December 2023. During the last 3 years, it has risen by +$19.42 million (+135.35%). RPTX annual SG&A is now at all-time high.RPTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.44 M
-$1.87 M-22.52%
30 September 2024
Summary:
Repare Therapeutics quarterly selling, general & administrative expenses is currently $6.44 million, with the most recent change of -$1.87 million (-22.52%) on 30 September 2024. Over the past year, it has dropped by -$1.42 million (-18.10%). RPTX quarterly SG&A is now -26.60% below its all-time high of $8.78 million, reached on 31 March 2022.RPTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.40 B
-$84.05 M-6.40%
30 September 2024
Summary:
Repare Therapeutics TTM selling, general & administrative expenses is currently -$1.40 billion, with the most recent change of -$84.05 million (-6.40%) on 30 September 2024. Over the past year, it has dropped by -$1.43 billion (-4326.00%). RPTX TTM SG&A is now -2697.11% below its all-time high of $33.85 million, reached on 31 March 2024.RPTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.7% | -18.1% | -4326.0% |
| 3 y3 years | +135.3% | -2.3% | -6077.6% |
| 5 y5 years | +1058.7% | +415.5% | -10000.0% |
RPTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +135.3% | -26.6% | at low | -148.9% | at low |
| 5 y | 5 years | at high | +1058.7% | -26.6% | +415.5% | -2697.1% | at low |
| alltime | all time | at high | +1803.3% | -26.6% | +524.4% | -2697.1% | at low |
Repare Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.44 M(-22.5%) | $32.03 M(-4.3%) |
| June 2024 | - | $8.32 M(-3.5%) | $33.45 M(-1.2%) |
| Mar 2024 | - | $8.62 M(-0.3%) | $33.85 M(+0.3%) |
| Dec 2023 | $33.76 M(+3.7%) | $8.65 M(+9.9%) | $33.76 M(+2.1%) |
| Sept 2023 | - | $7.87 M(-9.8%) | $33.05 M(-0.1%) |
| June 2023 | - | $8.72 M(+2.2%) | $33.09 M(+2.4%) |
| Mar 2023 | - | $8.53 M(+7.4%) | $32.31 M(-0.8%) |
| Dec 2022 | $32.56 M(+24.2%) | $7.94 M(+0.4%) | $32.56 M(+0.9%) |
| Sept 2022 | - | $7.90 M(-0.4%) | $32.26 M(+4.2%) |
| June 2022 | - | $7.94 M(-9.6%) | $30.95 M(+4.0%) |
| Mar 2022 | - | $8.78 M(+14.9%) | $29.75 M(+13.5%) |
| Dec 2021 | $26.21 M | $7.64 M(+15.8%) | $26.21 M(+12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $6.60 M(-2.2%) | $23.37 M(+12.5%) |
| June 2021 | - | $6.74 M(+28.7%) | $20.77 M(+19.4%) |
| Mar 2021 | - | $5.24 M(+9.2%) | $17.40 M(+21.3%) |
| Dec 2020 | $14.35 M(+166.6%) | $4.79 M(+20.0%) | $14.35 M(+23.9%) |
| Sept 2020 | - | $4.00 M(+18.5%) | $11.57 M(+31.1%) |
| June 2020 | - | $3.37 M(+54.5%) | $8.83 M(+36.1%) |
| Mar 2020 | - | $2.18 M(+7.9%) | $6.49 M(+20.6%) |
| Dec 2019 | $5.38 M(+84.7%) | $2.02 M(+61.9%) | $5.38 M(+60.3%) |
| Sept 2019 | - | $1.25 M(+21.1%) | $3.36 M(+59.3%) |
| June 2019 | - | $1.03 M(-4.1%) | $2.11 M(+95.9%) |
| Mar 2019 | - | $1.08 M | $1.08 M |
| Dec 2018 | $2.91 M(+64.3%) | - | - |
| Dec 2017 | $1.77 M | - | - |
FAQ
- What is Repare Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Repare Therapeutics?
- What is Repare Therapeutics annual SG&A year-on-year change?
- What is Repare Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Repare Therapeutics?
- What is Repare Therapeutics quarterly SG&A year-on-year change?
- What is Repare Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Repare Therapeutics?
- What is Repare Therapeutics TTM SG&A year-on-year change?
What is Repare Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of RPTX is $33.76 M
What is the all time high annual SG&A for Repare Therapeutics?
Repare Therapeutics all-time high annual selling, general & administrative expenses is $33.76 M
What is Repare Therapeutics annual SG&A year-on-year change?
Over the past year, RPTX annual selling, general & administrative expenses has changed by +$1.20 M (+3.70%)
What is Repare Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of RPTX is $6.44 M
What is the all time high quarterly SG&A for Repare Therapeutics?
Repare Therapeutics all-time high quarterly selling, general & administrative expenses is $8.78 M
What is Repare Therapeutics quarterly SG&A year-on-year change?
Over the past year, RPTX quarterly selling, general & administrative expenses has changed by -$1.42 M (-18.10%)
What is Repare Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of RPTX is -$1.40 B
What is the all time high TTM SG&A for Repare Therapeutics?
Repare Therapeutics all-time high TTM selling, general & administrative expenses is $33.85 M
What is Repare Therapeutics TTM SG&A year-on-year change?
Over the past year, RPTX TTM selling, general & administrative expenses has changed by -$1.43 B (-4326.00%)